Vertex Pharmaceuticals Incorporated
Climate Impact & Sustainability Data (2021, 2022, 2023)
Reporting Period: 2021
Environmental Metrics
Scope 1 Emissions:6,128 MTCO2e
Scope 2 Emissions:7,159 MTCO2e
ESG Focus Areas
- Climate Change
- Waste Management
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: CDP Climate Change Questionnaire, WBCSD/WRI GHG Protocol (2004, as updated January 2015)
Third-party Assurance: ERM Certification and Verification Services, Inc.
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Environmental
- Safety
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: WBCSD/WRI GHG Protocol (2004, as updated January 2015), OSHA Injury and Illness Recordkeeping and Reporting definitions
Third-party Assurance: ERM Certification & Verification Services Incorporated
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:12,558 tCO2e/year (Scope 1 & 2 Market-Based)
Scope 1 Emissions:7,670 tCO2e/year
Scope 2 Emissions:4,888 tCO2e/year
Scope 3 Emissions:474,129 tCO2e/year
Renewable Energy Share:49%
Water Consumption:169.3 megaliters/year
Waste Generated:1,689 tons/year
ESG Focus Areas
- Improve the Lives of People With Serious Diseases
- Foster a Culture of Innovation, Integrity and Inclusion
- Carefully Manage Our Operations and Environmental Footprint
- Make a Positive Impact in the Communities Where We Are Located
Environmental Achievements
- 53% reduction in absolute greenhouse gas (GHG) emissions since 2014
- 82% green-certified square footage in our buildings
- 100% renewable energy at our International Headquarters and R&D facility in the U.K.
- A- score on 2023 Climate Change survey for demonstrating environmental leadership
Social Achievements
- Expanded access to our CF medicines for more people around the world, with more than 60 countries where our medicines are reimbursed or accessible
- Strengthened our engagement with patient organizations
- Continued focus on recruiting, retaining and developing highly talented employees from a diverse range of backgrounds, promoting our employees’ continued well-being and professional development, and nurturing our unique culture
- $42+ million in charitable giving by Vertex and the Vertex Foundation
- 60% of employees volunteered during annual Global Day of Service
Governance Achievements
- 100% of employees completed annual code of conduct training
- 6 out of 11 Board directors are women and/or from underrepresented ethnic and racial groups
- New third-party risk management approach to more efficiently and effectively identify, mitigate and manage ongoing risk with third parties
Climate Goals & Targets
Medium-term Goals:
- Reduce Scope 1 and 2 GHG emissions by 42 percent by 2032
Environmental Challenges
- Increased cost for raw materials and scarcity of natural resources
- Potential impacts of drought on our locations in California and coastal flooding near our key facilities in Boston’s Seaport District
Mitigation Strategies
- Business continuity strategies and existing mitigation processes, including use of flood barriers, waterproofing, watertight doors and storm-resistant glass
- Decarbonization study at three of our largest research and manufacturing locations to identify opportunities to electrify these facilities and reduce our global GHG footprint
Supply Chain Management
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Drought
- Coastal flooding
Transition Risks
- Increased cost for raw materials and scarcity of natural resources
Reporting Standards
Frameworks Used: SASB
Certifications: LEED, BREEAM, SKA, Fitwel, My Green Lab
Third-party Assurance: ERM CVS
Awards & Recognition
- LEED Platinum certification for Jeffrey Leiden Center
- Award of Merit for Interior/Tenant Improvement from Engineering News-Record New England